Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 4 (1), 29-39

Effects of Piracetam on Developmental Dyslexia

Review

Effects of Piracetam on Developmental Dyslexia

C R Wilsher. Int J Psychophysiol.

Abstract

A new class of drugs (nootropics) are viewed from the perspective of their neuropsychological effect upon developmental dyslexia. Evidence from both the preclinical and clinical work conducted on Piracetam is briefly reviewed. The latest research on the effects of Piracetam in dyslexia shows a convergence of results. Attempts to replicate these results with dyslexia have only met with success in the areas of reading rate. In an attempt to find an independent replication of the Chase et al. (1984) finding, the author provides additional evidence on the effects of Piracetam on reading Rate X Accuracy in dyslexics.

Similar articles

  • Piracetam as an Aid to Learning in Dyslexia. Preliminary Report
    C Wilsher et al. Psychopharmacology (Berl) 65 (1), 107-9. PMID 116285. - Clinical Trial
    Sixteen male dyslexic children were seen again when adults and matched with 14 student volunteers for a 21-day trial of piracetam. It was found, using a double-blind cros …
  • Piracetam and Dyslexia: Effects on Reading Tests
    CR Wilsher et al. J Clin Psychopharmacol 7 (4), 230-7. PMID 3305591. - Clinical Trial
    Previous research has suggested that dyslexics treated with piracetam have shown improvements in reading skills, verbal memory and verbal conceptualizing ability, feature …
  • The Effects of Piracetam in Children With Dyslexia
    M Di Ianni et al. J Clin Psychopharmacol 5 (5), 272-8. PMID 3900148. - Clinical Trial
    Following previous research which suggests that piracetam improves performance on tasks associated with the left hemisphere, a 12-week, double-blind, placebo-controlled s …
  • Effect of Piracetam on Dyslexic's Reading Ability
    C Wilsher et al. J Learn Disabil 18 (1), 19-25. PMID 3881545. - Clinical Trial
  • Piracetam: A Review of Pharmacological Properties and Clinical Uses
    B Winblad. CNS Drug Rev 11 (2), 169-82. PMID 16007238. - Review
    Piracetam, a derivative of the neurotransmitter gamma-aminobutyric acid (GABA), has a variety of physiological effects that may result, at least in part, from the restora …
See all similar articles

Cited by 3 PubMed Central articles

MeSH terms

Feedback